全文获取类型
收费全文 | 24556篇 |
免费 | 1533篇 |
国内免费 | 176篇 |
专业分类
耳鼻咽喉 | 235篇 |
儿科学 | 523篇 |
妇产科学 | 467篇 |
基础医学 | 3687篇 |
口腔科学 | 259篇 |
临床医学 | 2323篇 |
内科学 | 6150篇 |
皮肤病学 | 365篇 |
神经病学 | 2119篇 |
特种医学 | 1072篇 |
外国民族医学 | 8篇 |
外科学 | 4213篇 |
综合类 | 69篇 |
一般理论 | 4篇 |
预防医学 | 1347篇 |
眼科学 | 211篇 |
药学 | 1356篇 |
中国医学 | 41篇 |
肿瘤学 | 1816篇 |
出版年
2023年 | 135篇 |
2022年 | 220篇 |
2021年 | 606篇 |
2020年 | 364篇 |
2019年 | 585篇 |
2018年 | 691篇 |
2017年 | 465篇 |
2016年 | 559篇 |
2015年 | 713篇 |
2014年 | 936篇 |
2013年 | 1204篇 |
2012年 | 1917篇 |
2011年 | 1892篇 |
2010年 | 1094篇 |
2009年 | 1104篇 |
2008年 | 1685篇 |
2007年 | 1698篇 |
2006年 | 1662篇 |
2005年 | 1703篇 |
2004年 | 1572篇 |
2003年 | 1481篇 |
2002年 | 1391篇 |
2001年 | 206篇 |
2000年 | 148篇 |
1999年 | 216篇 |
1998年 | 264篇 |
1997年 | 231篇 |
1996年 | 190篇 |
1995年 | 159篇 |
1994年 | 117篇 |
1993年 | 143篇 |
1992年 | 108篇 |
1991年 | 81篇 |
1990年 | 80篇 |
1989年 | 55篇 |
1988年 | 58篇 |
1987年 | 41篇 |
1986年 | 54篇 |
1985年 | 46篇 |
1984年 | 39篇 |
1983年 | 49篇 |
1982年 | 41篇 |
1981年 | 48篇 |
1980年 | 37篇 |
1979年 | 21篇 |
1978年 | 16篇 |
1977年 | 15篇 |
1976年 | 14篇 |
1975年 | 18篇 |
1972年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
951.
Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions 总被引:7,自引:0,他引:7
O'Toole D Palazzo L Hammel P Ben Yaghlene L Couvelard A Felce-Dachez M Fabre M Dancour A Aubert A Sauvanet A Maire F Lévy P Ruszniewski P 《Gastrointestinal endoscopy》2004,59(7):823-829
BACKGROUND: Benign pancreatic serous cystadenoma usually is morphologically distinguishable from mucinous cystadenomas, which require resection because of their malignant potential. A macrocystic variant of serous cystadenoma recently has been described, rendering this important distinction more difficult. The aim of this study was to determine the EUS and tumor marker characteristics of mucinous cystadenoma compared with macrocystic serous cystadenomas. METHODS: Medical records for consecutive patients seen between 1995 and 2002, with a histopathologic diagnosis of mucinous cystadenoma or macrocystic serous cystadenoma after surgery, who had undergone a detailed EUS examination, including EUS-guided FNA, were retrospectively reviewed. RESULTS: A resection specimen was available for 32 mucinous cystadenomas and 9 macrocystic serous cystadenomas. No significant differences were observed with regard to clinical data (age, gender, presence of symptoms), lesion size, and location within the pancreas. All mucinous cystadenomas had a discernible cyst wall (thickened, 66%; focal parietal nodules, 25%) compared with 56% of macrocystic serous cystadenomas (p<0.0001). A thick echo content also was more frequent in mucinous cystadenoma (56% vs. 11%; p=0.04; statistical significance removed by the Bonferroni correction). Microcysts were only observed in macrocystic serous cystadenomas (44%; p=0.0008). The combination of a cyst wall that is thickened and the absence of microcysts had a sensitivity of 100% and specificity of 78% for the diagnosis of mucinous cystadenoma compared with macrocystic serous cystadenoma. Although intracystic carbohydrate-associated antigen 72-4 and mucins M1 were non-discriminatory, low carcinoembryonic antigen (<5 ng/mL) and carbohydrate-associated antigen 19-9 (<50,000 U/mL) values were found in macrocystic serous lesions (respectively, 100% and 100%; p=0.0002 and p=0.0002). CONCLUSIONS: Although there is considerable overlap, helpful EUS characteristics that differentiate mucinous cystadenoma from macrocystic serous cystadenoma include a thick cyst wall and microcysts. These features, coupled with analysis of aspirated fluid for tumor markers (especially carcinoembryonic antigen), should help to confirm the diagnosis. 相似文献
952.
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas 总被引:6,自引:1,他引:6 下载免费PDF全文
Grange F Petrella T Beylot-Barry M Joly P D'Incan M Delaunay M Machet L Avril MF Dalac S Bernard P Carlotti A Esteve E Vergier B Dechelotte P Cassagnau E Courville P Saiag P Laroche L Bagot M Wechsler J 《Blood》2004,103(10):3662-3668
Bcl-2 protein expression has been associated with poor prognosis in patients with noncutaneous diffuse large B-cell lymphomas. In primary cutaneous large B-cell lymphomas, the location on the leg, the round-cell morphology defined as the predominance of centroblasts and immunoblasts over large centrocytes, and multiple skin lesions were identified as adverse prognostic factors. The prognostic value of bcl-2 protein expression has not been studied in large series of patients. We evaluated 80 primary cutaneous large B-cell lymphomas collected by the French Study Group on Cutaneous Lymphomas. The prognostic value of age, sex, number of lesions, cutaneous extent, location, serum lactate dehydrogenase (LDH) level, B symptoms, morphology, and bcl-2 protein expression was studied. The overall 5-year specific survival rate was 65%. In univariate analysis, advanced age, multiple skin lesions (n = 48), location on the leg (n = 25), round-cell morphology (n = 32), and bcl-2 expression (n = 39) were significantly related to death from lymphoma. In multivariate analysis, bcl-2 expression (P =.0003), multiple skin lesions (P =.004), and age remained independent prognostic factors. The 5-year specific survival rates in bcl-2-positive and bcl-2-negative patients were 41% and 89%, respectively (P <.0001). A new prognostic classification of primary cutaneous B-cell lymphoma should be based primarily on bcl-2 protein expression rather than the location of skin lesions. 相似文献
953.
Boniol M Dore JF Autier P 《The Journal of investigative dermatology》2008,128(2):481; author reply 481-481; author reply 482
954.
Cacoub P Halfon P Rosenthal E Pialoux G Benhamou Y Perronne C Pol S;Prospecth Study Group 《Journal of hepatology》2008,48(1):35-42
BACKGROUND/AIMS: To analyze the barriers to HCV treatment in HIV-HCV co-infected patients and their evolution between 2004 and 2006. METHODS: Three hundred and eighty HIV-HCV co-infected patients were prospectively included in surveys from November 22 to 29, 2004 (2004 survey), and 416 from April 3 to 10, 2006 (2006 survey). RESULTS: Patients in 2006 compared to those in 2004 had negative HCV RNA more often (24% vs. 12%). The rate of liver biopsy was similar (56% vs. 54%) while 24% had had a non-invasive liver damage assessment. The rate of previous treatment for HCV infection was higher (48% vs. 26%). The main reasons for HCV non-treatment have changed: HCV treatment deemed questionable (44% vs. 53%), lack of liver biopsy (18% vs. 33%), physicians' conviction of poor patient compliance (20% vs. 30%). In both surveys, HCV treated patients were more often of European origin, had better control of HIV infection, and had a liver damage assessment more often. CONCLUSIONS: The care of HIV-HCV co-infected patients has changed significantly in "real life". These results underline the importance of continuing efforts to educate physicians and patients in order to increase the access of co-infected patients to HCV treatment. 相似文献
955.
956.
Philippe Druet 《Journal of immunological methods》1992,150(1-2):177-184
957.
958.
959.
Primary ovarian insufficiency (POI) is a disorder associated with female infertility, which affects approximately 1% of women under 40 years of age. A genetic component has been suggested as one possible cause of the majority of cases of nonsyndromic forms. Newborn Ovary Homeobox (NOBOX) is an ovary-specific gene, playing a critical role in ovary in mice, as its absence leads to sterility mimicking a POI. In this study, we sequenced NOBOX in a cohort of 178 women with idiopathic POI. Among 19 identified variations, we described one nonsense (c.907C>T/p.R303X) and four missense (c.271G>T/p.G91W, c.349C>T/p.R117W, c.1025G>C/p.S342T, and c.1048G>T/p.V350L) NOBOX heterozygous mutations in 12 patients. We reproduced each of the five mutations and tested their effects on the signaling activity in transfected cells. We demonstrated that these mutations compromised the ability of the proteins to bind to and transactivate the well-known growth differentiation factor 9 (GDF9) promoter. The pattern of our findings suggests that the genetic mechanism in humans responsible for POI in women involves haploinsufficiency rather than dominant negative gene action. The identification, characterization, and the very high 6.2% prevalence of these new mutations in POI patients suggest considering NOBOX as the first autosomal candidate gene involved in this syndrome. 相似文献
960.
Morand PC Burgel PR Carlotti A Desmazes-Dufeu N Farhi D Martin C Kanaan R Mangialavori L Palangié E Dusser D Poyart C Hubert D 《Journal of clinical microbiology》2011,49(2):750-751
Tuberculosis (TB) is rarely observed in cystic fibrosis (CF) patients. We report the first case of mediastinal TB, associated with leg pain and skin rash, in an adult patient with CF, and discuss factors suggestive of TB in the course of CF. 相似文献